Suzhou Highfine Biotech Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	5,632	4,269	6,481	-	-	-
Market Cap Growth	33.39%	-34.13%	-	-	-	-
Enterprise Value	4,151	2,525	4,742	-	-	-
Last Close Price	52.65	39.61	59.09	-	-	-
PE Ratio	41.45	31.85	65.48	-	-	-
Forward PE	-	23.69	34.44	-	-	-
PS Ratio	10.09	9.45	16.67	-	-	-
PB Ratio	2.40	1.88	2.93	-	-	-
P/TBV Ratio	2.58	1.94	2.96	-	-	-
P/FCF Ratio	-	229.29	-	-	-	-
P/OCF Ratio	83.44	33.78	73.79	-	-	-
EV/Sales Ratio	7.43	5.59	12.20	-	-	-
EV/EBITDA Ratio	28.01	20.87	51.46	-	-	-
EV/EBIT Ratio	33.42	24.58	59.86	-	-	-
EV/FCF Ratio	-45.45	135.61	-	-	-	-
Debt / Equity Ratio	0.01	0.00	0.00	0.00	0.01	0.00
Debt / EBITDA Ratio	0.08	0.03	0.02	0.01	0.02	0.02
Debt / FCF Ratio	-	0.18	-	0.03	0.10	0.05
Asset Turnover	0.23	0.20	0.27	0.84	0.94	1.08
Inventory Turnover	2.68	2.35	2.13	2.65	3.02	3.15
Quick Ratio	9.13	25.54	27.86	1.96	2.31	2.52
Current Ratio	10.09	27.32	29.83	3.23	3.42	3.60
Return on Equity (ROE)	5.97%	5.98%	7.35%	30.27%	35.18%	18.61%
Return on Assets (ROA)	3.18%	2.77%	3.43%	16.65%	20.20%	13.69%
Return on Invested Capital (ROIC)	14.45%	17.68%	18.16%	42.78%	53.47%	33.73%
Return on Capital Employed (ROCE)	5.20%	4.50%	3.60%	28.90%	33.50%	21.60%
Earnings Yield	2.43%	3.14%	1.53%	-	-	-
FCF Yield	-1.62%	0.44%	-0.50%	-	-	-
Dividend Yield	0.76%	0.98%	0.42%	-	-	-
Payout Ratio	30.85%	29.98%	27.28%	15.65%	0.01%	0.08%
Buyback Yield / Dilution	0.76%	-16.87%	-14.40%	-0.16%	0.10%	-0.10%
Total Shareholder Return	1.51%	-15.89%	-13.98%	-0.16%	0.10%	-0.10%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.